Krilogy Financial LLC Invests $3.18 Million in Intuitive Surgical, Inc. $ISRG

Krilogy Financial LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, HoldingsChannel.com reports. The institutional investor purchased 7,109 shares of the medical equipment provider’s stock, valued at approximately $3,179,000.

Several other large investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in Intuitive Surgical during the second quarter valued at $2,569,260,000. Rakuten Investment Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth about $388,436,000. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after buying an additional 670,302 shares during the period. Jennison Associates LLC grew its position in shares of Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after buying an additional 528,359 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in Intuitive Surgical by 89.3% during the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after acquiring an additional 371,806 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Quarterly beat and procedure momentum support fundamentals — Intuitive’s Jan. quarter topped EPS and revenue estimates and management highlighted continued adoption of the da Vinci 5 platform, reinforcing the company’s growth narrative. MarketBeat: Growth Engine
• Positive Sentiment: Analyst coverage remains mixed but contains notable buy-side views — several firms keep buy/overweight ratings and high targets (e.g., Barclays, BTIG, Leerink), supporting investor conviction that upside remains if execution continues. Globe and Mail: Analyst Insights
• Neutral Sentiment: Technical and market-data focus — traders are watching the pullback and key moving averages (50‑day vs. 200‑day) using interactive charting tools, which can amplify short‑term moves but are not fundamental drivers. Barron’s Interactive Chart
• Neutral Sentiment: Short-interest figures in recent feeds appear anomalous (zeros/NaN) and likely aren’t a meaningful market driver today; treat those data points with caution.
• Negative Sentiment: Insider selling flagged — EVP Myriam Curet and VP Fredrik Widman disclosed multiple share sales in early February, with Curet reducing her holding materially; such filings often create short‑term negative sentiment. Curet SEC filing Widman SEC filing
• Negative Sentiment: Valuation questions and recent underperformance — financial press pieces are asking whether ISRG is still “priced for perfection” after a pullback, and analysts note the shares have materially underperformed the market in recent months, which may sustain near‑term caution. Yahoo Finance: Valuation Debate Zacks: Share Pullback

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 464 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total transaction of $254,499.36. Following the sale, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. The trade was a 77.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Fredrik Widman sold 133 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 56,189 shares of company stock valued at $30,785,441 over the last quarter. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on ISRG shares. Rothschild & Co Redburn lifted their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. UBS Group reissued a “neutral” rating on shares of Intuitive Surgical in a report on Thursday, January 15th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Leerink Partners increased their target price on Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $496.12 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The firm has a market capitalization of $176.19 billion, a PE ratio of 62.88, a price-to-earnings-growth ratio of 3.84 and a beta of 1.65. The stock has a fifty day moving average of $545.21 and a two-hundred day moving average of $510.52.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company earned $2.21 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.